JUL 30, 2016 12:44 PM PDT

Natural Pain Causing Substance Actually Acts As Painkiller

WRITTEN BY: Julianne Chiaet
Lesly B. Juarez via Unsplash.com
Substance P, a natural substance produced in the central nervous system and peripheral nervous system, is known to activate pain. However, new research shows that the substance only causes pain in the central nervous system - and actually acts as a painkiller in the peripheral nervous system. 

This research points to why many painkillers have failed to pass clinical trials over the last 20 years. These failed drugs successfully targeted Substance P in the lab. Yet, in clinical trials, they ended up unintentionally suppressing the substance’s ability to kill pain in the peripheral nervous system. Thus, after much funding, the drugs would always mysteriously fail. 

Substance P works as a painkiller in the peripheral nervous system by dampening the nerve cells' responsiveness and excitability. Oppositely, Substance P drives pain in the central nervous system by triggering signals that excite neurons. 

"We were really surprised by the results,” said lead researcher Nikita Gamper, from the University of Leeds. "Substance P is described in the literature as a molecule that gets nerve cells excited and promotes pain. But we've discovered a paradox - that in the peripheral nervous system, it acts as one of the body's natural painkillers and actually suppresses pain."
 

"Drugs like morphine hijack the body's natural painkilling mechanisms, such as… endorphins,” said lead researcher Nikita Gamper, from the University of Leed. However, because such drugs “act within the central nervous system, they can affect other brain cells that use similar pathways, leading to side effects such as addiction or sleepiness."

Gamper is now focusing on Substance P’s role in chronic pain. "If we could develop a drug to mimic the mechanism that Substance P uses, and ensured it couldn't pass the blood-brain barrier into the CNS, … it's likely it could suppress pain with limited side effects,” Gamper said. 

The research was openly published in the journal Antioxidants & Redox Signaling

Sources: "Redox-Dependent Modulation of T-Type Ca2 Channels in Sensory Neurons Contributes to Acute Anti-Nociceptive Effect of Substance P” in the journal Antioxidants & Redox Signaling, University of Leeds press release via Science Daily 


 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
OCT 13, 2020
Neuroscience
Sleep Apnea and Alzheimer's Damage Brain in Same Way
OCT 13, 2020
Sleep Apnea and Alzheimer's Damage Brain in Same Way
Sleep apnea is characterized by breathing that repeatedly stops and starts, loud snoring, restless sleep, and sleepiness ...
OCT 18, 2020
Microbiology
Mouth Microbes Play a Role in Oral Cancer Development
OCT 18, 2020
Mouth Microbes Play a Role in Oral Cancer Development
Oral hygiene is not only important for keeping teeth and gums healthy; it can also affect a person's health in general.
OCT 26, 2020
Cancer
Investigating the Receptor Protein FPR1 in Brain Cancer
OCT 26, 2020
Investigating the Receptor Protein FPR1 in Brain Cancer
Amongst the more common targets for cancer therapies are cell surface receptors. These receptors are proteins – us ...
OCT 29, 2020
Cannabis Sciences
Hemp 10 Years from Now
OCT 29, 2020
Hemp 10 Years from Now
The hemp industry has experienced major growth in recent years, largely due to legalization in many US states. Today, th ...
Loading Comments...